Role of Hedgehog Signaling in Chronic Gastritis and Metaplasia

Hedgehog 信号传导在慢性胃炎和化生中的作用

基本信息

项目摘要

The goals of the current application are to understand the role of the Sonic Hedgehog (Shh) ligand and components ofthe Hh signaling apparatus Glil and Gli2 in the homeostasis and subsequent translation of chronic gastritis to metaplasia, a preneoplastic lesion. It has been reported in human epidemiologic studies as well as mouse models that the development of tumors in the gastric corpus versus the antrum emerge ostensibly in response to different signals. As a result, we have focused our attention on cellular decisions that impact the emergence of corpus versus antral tumors. Studies completed during the prior funding period confirmed regional differences in the expression and function of the Shh ligand and the Hh signaling componets Glil-expressed in myeloid cell populations; and Gli2-expressed primarily in both antral mesenchyme and a hyperplastic.antral epithelium. In the antrum, primary cilia, an organelle linked to Gli2 function, and gastrin are important to normal gastric homeostasis, characterized by gastric acidity. We previously demonstrated that gastrin null mice develop antral tumors and recently reported an increase in epithelial Gli2 expression in these hyperplastic antrums. Moreover ectopic expression of Gli2 in the gastric epithelium suppresses gastrin expression and ultimately results in antral hyperplasia. In a mouse model of Helicobacter infection, we found that the corpus exhibits greater dependency on canonical Hh signaling than the antrum. In particular during /7e//co/)ac/er infection, the corpus acutely recruits Glil-expressing myeloid cells (<2 months) that appear to modify their surface markers in the chronically inflamed stomach to markers indicative of myeloid-derived suppressor cells (MDSCs). By 6 months, corpus metaplasia has emerged correlating with Gli1+-MDSCs their secretion of IL-lp. Thus we hypothesize that the contribution of Hh signaling to gastric homeostasis and hyperplasia differs according to their location in the stomach (corpus versus antrum). Aim 1 will examine the role of Hh signaling in antral homeostasis and in particular, its role in regulating gastrin and their relationship to primary cilia. Aim 2 will establish whether the proinflammatory cytokine IL-ip is sufficient to induce epithelial expression of Gli2 and antral hyperplasia. Crosstalk with the Notch signaling pathway will be explored in collaboration with Subproject #3. Aim 3 will test the hypothesis that the time lag between chronic gastritis and metaplasia in the corpus requires pathogen-related maturation of myeloid cells in the inflamed gastric environment. The role of Hh signaling through Glil will be compared to Hh signaling in the inflamed intestine in collaboration with Subproject #1. RELEVANCE (See instructions): This Subproject will define the functional differences in Hedgehog signaling components in gastric homeostasis that ultimately alters cellular decisions in the regional response to environmental stress, e.g., chronic inflammation and preneoplastic lesions such as metaplasia.
本申请的目标是理解Sonic Hedgehog(Shh)配体的作用, Hh信号传导装置Glil和Gli 2在体内平衡和随后的翻译中的组成部分, 慢性胃炎转化为化生,一种癌前病变。据人类流行病学研究报告, 以及胃体肿瘤发展与胃窦肿瘤发展的小鼠模型, 表面上是对不同信号的反应。因此,我们将注意力集中在细胞决策上, 影响胃体肿瘤和胃窦肿瘤的发生。上一次供资期间完成的研究 期间证实了Shh配体和Hh信号传导的表达和功能的区域差异, Glil-在髓样细胞群中表达; Gli 2-主要在胃窦和结肠中表达。 间充质和增生的胃窦上皮。在胃窦,初级纤毛,一种与Gli 2相连的细胞器, 功能和胃泌素对于以胃酸为特征的正常胃内稳态是重要的。我们 先前证明胃泌素缺失小鼠发生胃窦肿瘤,最近报道胃窦肿瘤的增加。 上皮细胞Gli 2表达。此外,Gli 2在胃中的异位表达 上皮抑制胃泌素表达并最终导致胃窦增生。的小鼠模型中 在幽门螺杆菌感染的情况下,我们发现,与正常人相比, 胃窦特别是在急性感染期间,小体急性募集表达GIL的髓样细胞, 细胞(<2个月)似乎将其在慢性炎症胃中的表面标记物修饰为标记物 指示骨髓源性抑制细胞(MDSC)。到6个月时,已出现体化生 与Gli 1 +-MDSC分泌IL-1 β相关。因此,我们假设Hh的贡献 对胃内稳态和增生的信号传导根据它们在胃(胃体)中的位置而不同 相对于窦)。目的1将研究Hh信号在胃窦稳态中的作用,特别是它在 调节胃泌素及其与初级纤毛的关系。目标2将确定促炎性因子是否 细胞因子IL-1 β足以诱导Gli 2的上皮表达和胃窦增生。串扰与 Notch信号通路将与子项目#3合作探索。目标3将检验假设 慢性胃炎和胃体化生之间的时间差需要病原体相关的 在发炎的胃环境中髓样细胞的成熟。Hh信号通过Glil的作用将是 与子项目#1合作的发炎肠道中的Hh信号传导相比。 相关性(参见说明): 这个子项目将定义胃粘膜中Hedgehog信号成分的功能差异, 最终改变细胞对环境应激的区域反应中的决定的内稳态,例如, 慢性炎症和癌前病变如化生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JUANITA L. MERCHANT其他文献

JUANITA L. MERCHANT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JUANITA L. MERCHANT', 18)}}的其他基金

MDSC Polarization and Helicobacter-Induced Gastric Metaplasia
MDSC 极化和螺杆菌诱导的胃化生
  • 批准号:
    10164764
  • 财政年份:
    2018
  • 资助金额:
    $ 42.9万
  • 项目类别:
MDSC Polarization and Helicobacter-induced Gastric Metaplasia
MDSC 极化和螺杆菌诱导的胃化生
  • 批准号:
    10687293
  • 财政年份:
    2018
  • 资助金额:
    $ 42.9万
  • 项目类别:
Mechanisms of Gastrointestinal Growth and Transformation
胃肠道生长和转化的机制
  • 批准号:
    8088362
  • 财政年份:
    2010
  • 资助金额:
    $ 42.9万
  • 项目类别:
Mechanisms of Gastrointestional Growth & Transformation
胃肠生长机制
  • 批准号:
    7895949
  • 财政年份:
    2009
  • 资助金额:
    $ 42.9万
  • 项目类别:
Cellular Decisions of Differentiation in the GI Tract
胃肠道分化的细胞决定
  • 批准号:
    7898168
  • 财政年份:
    2009
  • 资助金额:
    $ 42.9万
  • 项目类别:
MOLECULAR BIOLOGY CORE
分子生物学核心
  • 批准号:
    7002129
  • 财政年份:
    2005
  • 资助金额:
    $ 42.9万
  • 项目类别:
Altering Gastric Epithelial Cell Differentiation
改变胃上皮细胞分化
  • 批准号:
    6698037
  • 财政年份:
    2003
  • 资助金额:
    $ 42.9万
  • 项目类别:
Altering Gastric Epithelial Cell Differentiation
改变胃上皮细胞分化
  • 批准号:
    7174208
  • 财政年份:
    2003
  • 资助金额:
    $ 42.9万
  • 项目类别:
Altering Gastric Epithelial Cell Differentiation
改变胃上皮细胞分化
  • 批准号:
    6858685
  • 财政年份:
    2003
  • 资助金额:
    $ 42.9万
  • 项目类别:
Altering Gastric Epithelial Cell Differentiation
改变胃上皮细胞分化
  • 批准号:
    6577518
  • 财政年份:
    2003
  • 资助金额:
    $ 42.9万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 42.9万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 42.9万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 42.9万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 42.9万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 42.9万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 42.9万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 42.9万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 42.9万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 42.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了